PRCT vs. NVO
Compare and contrast key facts about PROCEPT BioRobotics Corporation (PRCT) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PRCT or NVO.
Correlation
The correlation between PRCT and NVO is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PRCT vs. NVO - Performance Comparison
Key characteristics
PRCT:
0.03
NVO:
-1.25
PRCT:
0.64
NVO:
-1.92
PRCT:
1.07
NVO:
0.75
PRCT:
0.04
NVO:
-0.87
PRCT:
0.10
NVO:
-1.81
PRCT:
20.70%
NVO:
28.67%
PRCT:
65.88%
NVO:
41.46%
PRCT:
-63.51%
NVO:
-70.96%
PRCT:
-46.68%
NVO:
-59.68%
Fundamentals
PRCT:
$2.91B
NVO:
$285.37B
PRCT:
-$1.75
NVO:
$3.42
PRCT:
12.95
NVO:
0.98
PRCT:
7.23
NVO:
11.88
PRCT:
$179.96M
NVO:
$225.05B
PRCT:
$110.80M
NVO:
$190.45B
PRCT:
-$58.27M
NVO:
$113.24B
Returns By Period
In the year-to-date period, PRCT achieves a -34.14% return, which is significantly lower than NVO's -31.39% return.
PRCT
-34.14%
-8.36%
-23.09%
5.66%
N/A
N/A
NVO
-31.39%
-25.10%
-50.02%
-51.72%
14.53%
9.70%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PRCT vs. NVO — Risk-Adjusted Performance Rank
PRCT
NVO
PRCT vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for PROCEPT BioRobotics Corporation (PRCT) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PRCT vs. NVO - Dividend Comparison
PRCT has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 2.78%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRCT PROCEPT BioRobotics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 2.78% | 1.68% | 0.99% | 1.18% | 1.34% | 1.86% | 2.12% | 2.46% | 2.13% | 3.94% | 1.31% | 1.96% |
Drawdowns
PRCT vs. NVO - Drawdown Comparison
The maximum PRCT drawdown since its inception was -63.51%, smaller than the maximum NVO drawdown of -70.96%. Use the drawdown chart below to compare losses from any high point for PRCT and NVO. For additional features, visit the drawdowns tool.
Volatility
PRCT vs. NVO - Volatility Comparison
PROCEPT BioRobotics Corporation (PRCT) has a higher volatility of 18.98% compared to Novo Nordisk A/S (NVO) at 15.88%. This indicates that PRCT's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
PRCT vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between PROCEPT BioRobotics Corporation and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities